• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

February 25-26, 2014: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Agenda- February 25, 2014

Food and Drug Administration
Cellular, Tissue and Gene Therapies Advisory Committee
Meeting #59
February 25-26, 2014

Agenda: Tuesday, February 25, 2014
8:00 a.m. Opening Remarks
Evan Snyder, M.D., Ph.D., Chair

Conflict of Interest Statement
Gail Dapolito, Designated Federal Officer

Introduction of Members
Topic I: Oocyte Modification in Assisted Reproduction for the Prevention of Transmission of Mitochondrial disease or treatment of Infertility
8:15 FDA Introduction
Celia Witten, Ph.D., M.D.
Office of Cellular, Tissue and Gene Therapies
8:20 FDA Presentation
Deborah Hursh, Ph.D.
Office of Cellular, Tissue and Gene Therapies
Research and Science Presentations
8:40 Gerald Shadel, Ph.D.
Yale University
9:05 Q&A
9:20 Salvatore DiMauro, M.D.
Columbia University
9:45 Q&A
10:00 Break
10:15 Marc-André Sirard, D.M.V., Ph.D.
Université Laval
10:40 Q&A
10:55 Keith Latham, Ph.D.
Michigan State University
11:20 Q&A
11:35 Shoukhrat Mitalipov, Ph.D.
Oregon Health and Science University
11:55 Q&A
12:10 p.m. Dieter Egli, Ph.D.
Columbia University
New York Stem Cell Foundation Research Institute
12:30 Q&A
12:45 Lunch
1:45 Mary Herbert, Ph.D.
Newcastle University
2:05 Q&A
2:20 Open Public Hearing
3:20 Break
3:30 Committee Discussion of Questions
5:30 p.m. Adjourn